Metformin in Women With Type 2 Diabetes in Pregnancy Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.
Also called NCT01353391
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT01353391
-
- Other papers using this trial's data
- Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01353391. Randomized; quadruple masking; primary purpose treatment. Start 2011-05-25 (actual); primary completion 2019-06-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin in Women With Type 2 Diabetes in Pregnancy Trial
- Acronym
- MiTy
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo Comparator
- Lead sponsor
- Mount Sinai Hospital, Canada
- Collaborator
- University Health Network, Toronto
- Collaborator
- Sunnybrook Research Institute
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct01353391- Content hash
9d30be92cf2df92a035b9be8b3cd8bf604a8548946f4a24b326308c8855e9fd7